CTOs on the Move

Herewith

www.herewith.com

 
Herewith is a company that provides a platform for families to find and hire in-home senior care professionals. Their platform offers personalized caregiver matching, innovative care coordination services, and opt-in safety alerts.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.herewith.com
  • 1602, Babcock Street
    Costa Mesa, CA USA 92627
  • Phone: 415.506.9776

Executives

Name Title Contact Details

Similar Companies

General Healthcare Resources

General Healthcare Resources is a Plymouth Meeting, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Desktop Health

Desktop Health is a leading global provider of professional-grade 3D printing solutions. Our company invents, develops, manufactures and sells 3D printers and proprietary materials worldwide.

Boehringer Ingelheim

For more than 130 years, Boehringer Ingelheim has been committed to the research, development, and manufacturing of new medications with high therapeutic value for people and animals. As a family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in research and development. We are proud of addressing some of the most challenging healthcare issues. Our vision – value through innovation – has always characterized our collaborative work, and is for us simultaneously a fundamental requirement and a driving force. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees.

Ovid Therapeutics

Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.

VNUS Medical Technologies

VNUS Medical Technologies, Inc. is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.